Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43,411,663
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
16,387,741
-
Shares change
-
+1,527,478
-
Total reported value, excl. options
-
$30,972,798
-
Value change
-
+$2,743,682
-
Put/Call ratio
-
303%
-
Number of buys
-
23
-
Number of sells
-
-35
-
Price
-
$1.89
Significant Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q1 2024
89 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q1 2024.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16,387,741 shares
of 43,411,663 outstanding shares and own 37.7% of the company stock.
Largest 10 shareholders include Bleichroeder LP (2,755,028 shares), Slate Path Capital LP (2,402,455 shares), VANGUARD GROUP INC (2,283,362 shares), BlackRock Inc. (2,244,103 shares), GEODE CAPITAL MANAGEMENT, LLC (838,531 shares), STATE STREET CORP (759,795 shares), Robertson Stephens Wealth Management, LLC (478,500 shares), DIMENSIONAL FUND ADVISORS LP (431,308 shares), NORTHERN TRUST CORP (365,182 shares), and MILLENNIUM MANAGEMENT LLC (362,090 shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.